Yarrow Bioscience, Inc. (YARW): Operating Cash Flow
-$33.12M
Year ended 2025-12-31
-$16.93M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$33.12M | n/m | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | -$33.97M | n/m | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | -$25.34M | n/m | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | -$29.20M | n/m | 2024-03-01, From 2022-01-01 |
| 2021-12-31 | -$56.37M | n/m | 2023-03-14, From 2021-01-01 |
| 2020-12-31 | -$137.08M | n/m | 2022-03-17, From 2020-01-01 |
| 2019-12-31 | -$73.39M | n/m | 2021-03-04, From 2019-01-01 |
| 2018-12-31 | -$68.66M | n/c | 2021-03-04, From 2018-01-01 |
| 2017-12-31 | -$28.22M | n/m | 2020-03-03, From 2017-01-01 |
| 2016-12-31 | -$2.27M | n/c | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | -$4.18M | n/a | 2018-03-28, From 2015-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | -$33.12M | n/m |
| Silence Therapeutics plc (SLN) | 2025-12-31 | -$62.27M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | -$5.93M | n/m |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$16.19M | n/m |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | -$10.98M | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | -$3.95M | n/m |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | -$57.62M | n/m |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | -$396.0K | n/m |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | -$30.97M | n/m |
Compare YARW, SLN, ELAB, VCNX side by side · Screen every company in Pharmaceutical Preparations ↗